I now have comprehensive content across definition, epidemiology, pathogenesis, risk factors, classification, diagnosis, associated anomalies, screening, prognosis, and management. Let me compose a thorough answer.
Neural Tube Defects (NTDs)
Definition
An open neural tube defect (ONTD) is an embryologic defect in formation of the posterior vertebral arches of the spine, exposing the neural elements. It is also referred to as spina bifida or spinal dysraphism.
— Creasy & Resnik's Maternal-Fetal Medicine, p. 585
Embryology & Pathogenesis
The embryonic neural tube forms via neurulation — shaping, folding, and midline fusion of the neural plate — normally complete by day 25 after conception. ONTD results from failed caudal fusion of the neural tube (defect in primary neurulation), leaving neural tissue exposed.
Epidemiology
- Occurs in approximately 1:1,000 live births
- One of the most common congenital CNS malformations
Risk Factors
| Risk Factor | Odds Ratio / Risk |
|---|
| Prior affected pregnancy | 3–5% recurrence |
| Folate antagonists (valproic acid, carbamazepine) | ~1–2% risk |
| Folic acid deficiency (<400 mcg/day) | OR 3.72 (95% CI 1.77–7.81) |
| Pregestational diabetes (T1 or T2 DM) | OR 2.88 (95% CI 1.79–4.65) |
| Periconceptional fever (≥101°F) | OR 2.4 (95% CI 1.5–4.0) |
| Maternal obesity (BMI ≥30) | OR 1.79 (95% CI 1.51–2.13) |
| MTHFR mutation (677C>T) | OR 1.34 (95% CI 1.17–1.54) |
— Creasy & Resnik's Maternal-Fetal Medicine, p. 585
Classification
ONTD is classified by what overlies the bony defect:
| Type | Description |
|---|
| Myelomeningocele | Sac containing spinal cord or other neural elements (most common) |
| Meningocele | Sac containing only meninges and CSF (no neural tissue) |
| Myeloschisis | Wide splaying of vertebral arch, no covering, neural tube completely exposed |
- Location: >80% are in the lumbosacral region, but can occur anywhere along the spinal column including the cervical spine.
Cranial Defects
- Anencephaly: Absent skull and brain. A lethal defect due to failure of the anterior neuropore to close.
- Encephalocele/Cephalocele: Herniation of brain/meninges through a calvarial defect (most commonly occipital).
Associated Anomalies
Chiari II Malformation (Arnold-Chiari)
Almost always associated with lumbosacral myelomeningocele. Features include:
- Small posterior fossa
- Downward displacement of the cerebellum, pons, medulla, and cervical cord through an enlarged foramen magnum
- Medullary kinking, elongated slit-like 4th ventricle, beaking of the tectum
- Hydrocephalus: Present in 25% at birth; 80% develop it following myelomeningocele repair
Other associated findings: hydrosyringomyelia, absent corpus callosum, cortical dysplasia.
— Grainger & Allison's Diagnostic Radiology, p. 1976
Diagnosis
Prenatal Ultrasound
First trimester (11–14 weeks): Abnormal posterior brain on midsagittal view — non-visualization of the brainstem, 4th ventricle (intracranial translucency), or cisterna magna — indicates high risk of open spina bifida. Sensitivity ~76.5%, specificity ~99.6%.
Second trimester (standard): Spine imaged in axial, sagittal, and coronal planes.
- Sagittal: Defect in the dorsal spine with overlying cystic mass
- Axial: V- or U-shaped splaying of posterior vertebral elements
- Coronal: Splayed posterior elements with midline defect
Key intracranial signs (indirect signs of spina bifida):
- Lemon sign: Inward scalloping of frontal bones (due to low-lying cerebellum)
- Banana sign: Cerebellum wrapped around the brainstem (Chiari II)
- Ventriculomegaly / hydrocephalus
- Absent or compressed cisterna magna
Sagittal ultrasound at 20 weeks showing disruption of posterior spinal elements with overlying cystic mass, consistent with myelomeningocele.
Maternal Serum AFP (MSAFP)
- Elevated MSAFP (typically >2.0–2.5 MoM) at 15–20 weeks is the primary biochemical screen for ONTD
- Amniotic fluid AFP and acetylcholinesterase confirm the diagnosis
Fetal MRI
Useful for determining lesion level, size of bony defect, and associated intracranial anomalies.
Prognosis
Prognosis depends primarily on:
- Lesion level (higher = worse motor/sensory deficit)
- Lesion type (myeloschisis worse than meningocele)
- Associated anomalies (hydrocephalus, Chiari II severity)
Typical outcomes with myelomeningocele:
- Lower limb paralysis and sensory loss below the lesion level
- Neurogenic bladder and bowel (nearly universal)
- Hydrocephalus requiring VP shunt (~80% after repair)
- Cognitive outcomes range from normal to moderate delay depending on shunt complications and degree of Chiari II malformation
Management
Prevention
- Folic acid supplementation: 400 mcg/day periconceptionally for all women; 4 mg/day for women with a prior NTD-affected pregnancy (prescription-strength dose)
— Harriet Lane Handbook, p. 1959
Prenatal
- Detailed ultrasound and fetal MRI for lesion characterization
- Referral to multidisciplinary fetal center
- Fetal surgery (in utero myelomeningocele repair): The MOMS trial showed that prenatal repair (at 19–25 weeks) reduces the need for VP shunting and improves motor outcomes compared to postnatal repair. Performed at specialized centers.
- Delivery typically by cesarean section to minimize trauma to the exposed neural sac
Postnatal
- Neonatal neurosurgery: Back closure within 24–48 hours of birth to prevent infection
- Neurosurgical management of hydrocephalus (VP shunt)
- Urologic evaluation and management of neurogenic bladder
- Orthopedic and rehabilitation involvement
- Long-term multidisciplinary follow-up
Screening Summary
| Test | Timing | Marker |
|---|
| Nuchal translucency + posterior brain | 11–14 weeks | Absent IT/cisterna magna |
| MSAFP | 15–20 weeks | Elevated AFP |
| Anatomy ultrasound | 18–22 weeks | Lemon/banana signs, spinal defect |
| Amniotic fluid AFP + AChE | When needed | Confirms open defect |